Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus

A. M. Vicari, S. V. D'Angelo, S. Testa, G. Comi, G. Galardi, E. Orsi, A. D'Angelo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The fibrinolytic system was investigated in 38 patients (21 males and 17 females) affected by type 1 diabetes mellitus (18 free from complications, 10 with retinopathy, and 10 with autonomic neuropathy) and in 8 healthy controls. Two separate fibrinolysis-stimulating tests were done: standardized venous occlusion and 1-desamino-8-D-arginine vasopressin infusion. Plasma tissue plasminogen activator antigen and activity and plasma plasminogen activator inhibitor activity were measured. All the patients were in good metabolic control (mean HbA(1c) 7.4%, range 6.1-8.0%). No significant differences were observed either between the diabetic patients and the control subjects, nor among the subgroups of diabetic patients. The fibrinolytic system is probably not involved in type 1 diabetes mellitus.

Original languageEnglish
Pages (from-to)516-519
Number of pages4
JournalHormone and Metabolic Research
Volume24
Issue number11
Publication statusPublished - 1992

Fingerprint

Plasminogen Inactivators
Tissue Plasminogen Activator
Medical problems
Type 1 Diabetes Mellitus
Plasmas
Arginine Vasopressin
Deamino Arginine Vasopressin
Fibrinolysis
Thermodynamic properties
Antigens

Keywords

  • Fibrinolysis
  • Plasminogen activator inhibitor
  • Plasminogen activitor
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus. / Vicari, A. M.; D'Angelo, S. V.; Testa, S.; Comi, G.; Galardi, G.; Orsi, E.; D'Angelo, A.

In: Hormone and Metabolic Research, Vol. 24, No. 11, 1992, p. 516-519.

Research output: Contribution to journalArticle

@article{49c5f623f06941ec9a76f9a881ed3ed0,
title = "Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus",
abstract = "The fibrinolytic system was investigated in 38 patients (21 males and 17 females) affected by type 1 diabetes mellitus (18 free from complications, 10 with retinopathy, and 10 with autonomic neuropathy) and in 8 healthy controls. Two separate fibrinolysis-stimulating tests were done: standardized venous occlusion and 1-desamino-8-D-arginine vasopressin infusion. Plasma tissue plasminogen activator antigen and activity and plasma plasminogen activator inhibitor activity were measured. All the patients were in good metabolic control (mean HbA(1c) 7.4{\%}, range 6.1-8.0{\%}). No significant differences were observed either between the diabetic patients and the control subjects, nor among the subgroups of diabetic patients. The fibrinolytic system is probably not involved in type 1 diabetes mellitus.",
keywords = "Fibrinolysis, Plasminogen activator inhibitor, Plasminogen activitor, Type 1 diabetes mellitus",
author = "Vicari, {A. M.} and D'Angelo, {S. V.} and S. Testa and G. Comi and G. Galardi and E. Orsi and A. D'Angelo",
year = "1992",
language = "English",
volume = "24",
pages = "516--519",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "11",

}

TY - JOUR

T1 - Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus

AU - Vicari, A. M.

AU - D'Angelo, S. V.

AU - Testa, S.

AU - Comi, G.

AU - Galardi, G.

AU - Orsi, E.

AU - D'Angelo, A.

PY - 1992

Y1 - 1992

N2 - The fibrinolytic system was investigated in 38 patients (21 males and 17 females) affected by type 1 diabetes mellitus (18 free from complications, 10 with retinopathy, and 10 with autonomic neuropathy) and in 8 healthy controls. Two separate fibrinolysis-stimulating tests were done: standardized venous occlusion and 1-desamino-8-D-arginine vasopressin infusion. Plasma tissue plasminogen activator antigen and activity and plasma plasminogen activator inhibitor activity were measured. All the patients were in good metabolic control (mean HbA(1c) 7.4%, range 6.1-8.0%). No significant differences were observed either between the diabetic patients and the control subjects, nor among the subgroups of diabetic patients. The fibrinolytic system is probably not involved in type 1 diabetes mellitus.

AB - The fibrinolytic system was investigated in 38 patients (21 males and 17 females) affected by type 1 diabetes mellitus (18 free from complications, 10 with retinopathy, and 10 with autonomic neuropathy) and in 8 healthy controls. Two separate fibrinolysis-stimulating tests were done: standardized venous occlusion and 1-desamino-8-D-arginine vasopressin infusion. Plasma tissue plasminogen activator antigen and activity and plasma plasminogen activator inhibitor activity were measured. All the patients were in good metabolic control (mean HbA(1c) 7.4%, range 6.1-8.0%). No significant differences were observed either between the diabetic patients and the control subjects, nor among the subgroups of diabetic patients. The fibrinolytic system is probably not involved in type 1 diabetes mellitus.

KW - Fibrinolysis

KW - Plasminogen activator inhibitor

KW - Plasminogen activitor

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0026447874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026447874&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 516

EP - 519

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 11

ER -